Search
+
    SEARCHED FOR:

    EMCURE PHARMACEUTICALS

    AMFI reshuffle: Jio Platforms and NSE may get largecap status, Vedanta may become midcap in H1 CY27

    Nuvama expects Jio Platforms and NSE to enter AMFI's largecap category in its H1 CY27 reshuffle, while Vedanta may move to midcap status. The proposed changes also include upgrades and downgrades across midcap and smallcap stocks, with revised market-cap thresholds estimated at Rs 1.12 lakh crore and Rs 36,700 crore.

    PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horses

    HDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 2083. He favours largecaps for valuation comfort, highlights selective stock opportunities and urges investors to prioritise earnings visibility and disciplined asset allocation.

    Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%

    Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.

    Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 crore

    Emcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substantial growth. Revenue surged from Rs 2,269.82 crore to Rs 2,820.47 crore during this period, with international operations increasing by 34 per cent. Additionally, domestic revenue witnessed an 11.1 per cent rise, as company leaders expressed confidence in sustaining this positive trend through the latter half of FY27.

    Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 crore

    Emcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore. Revenue grew 24.3%, while EBITDA rose 30.9%, supported by strong international business growth.

    Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun Pharma

    Indian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC faced a decline in consolidated net profit, impacted by the cigarette business, despite revenue growth. Marico saw a significant rise in net profit and expanding EBITDA margins during the quarter. Container Corporation of India reported a subdued performance with a slight decline in net profit compared to last year.

    The Economic Times
    BACK TO TOP